Brain metastasis in head and neck squamous cell carcinoma after immune check point inhibitors treatment

被引:1
|
作者
Lorini, Luigi [1 ]
Merlano, Marco [2 ,3 ]
Licitra, Lisa [4 ]
Ravanelli, Marco [5 ]
Bossi, Paolo [6 ]
机构
[1] Univ Brescia, Dept Med & Surg Specialties Radiol Sci & Publ Hlt, Med Oncol Unit, Brescia, Italy
[2] Translat Res ARCO Fdn Cuneo, Cuneo, Italy
[3] FPO IRCCS Candiolo, Candiolo Canc Inst, Turin, Italy
[4] Fdn IRCCS Ist Nazl Tumori Milano, Head & Neck Med Oncol Dept, Milan, Italy
[5] Univ Brescia, Dept Radiol, Brescia, Italy
[6] Univ Brescia, ASST Spedali Civili, Dept Med & Surg Specialties Radiol Sci & Publ Hlt, Med Oncol, Brescia, Italy
关键词
LOCALLY ADVANCED HEAD; NIVOLUMAB; CHEMOTHERAPY; RECURRENT; PATTERNS; CANCERS; PATIENT;
D O I
10.1016/j.oraloncology.2020.105138
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [11] Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma
    Oliva, M.
    Spreafico, A.
    Taberna, M.
    Alemany, L.
    Coburn, B.
    Mesia, R.
    Siu, L. L.
    ANNALS OF ONCOLOGY, 2019, 30 (01) : 57 - 67
  • [12] Immune Check-Point Inhibitors and Standard Chemoradiotherapy in Definitive Head and Neck Cancer Treatment
    De Felice, Francesca
    Musio, Daniela
    Tombolini, Vincenzo
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (05):
  • [13] Current and Future Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma
    Park, Jong Chul
    Krishnakumar, Hari N.
    Saladi, Srinivas Vinod
    CURRENT ONCOLOGY, 2022, 29 (06) : 4185 - 4198
  • [14] PDE5 inhibitors for the immune therapy of head and neck squamous cell carcinoma
    Serafini, P.
    Weed, D.
    Vella, J.
    Delafuente, A.
    Gomez, C. R.
    Rodriguez, Z.
    Walker, G.
    IMMUNOLOGY, 2012, 137 : 719 - 719
  • [15] Angiogenesis Inhibitors for Head and Neck Squamous Cell Carcinoma Treatment: Is There Still Hope?
    Hyytiainen, Aini
    Wahbi, Wafa
    Vayrynen, Otto
    Saarilahti, Kauko
    Karihtala, Peeter
    Salo, Tuula
    Al-Samadi, Ahmed
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [16] mTOR Inhibitors and its Role in the Treatment of Head and Neck Squamous Cell Carcinoma
    Shaun A. Nguyen
    David Walker
    M. Boyd Gillespie
    J. Silvio Gutkind
    Terry A. Day
    Current Treatment Options in Oncology, 2012, 13 : 71 - 81
  • [17] mTOR Inhibitors and its Role in the Treatment of Head and Neck Squamous Cell Carcinoma
    Nguyen, Shaun A.
    Walker, David
    Gillespie, M. Boyd
    Gutkind, J. Silvio
    Day, Terry A.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2012, 13 (01) : 71 - 81
  • [18] Intracardiac metastasis from head and neck squamous cell carcinoma
    Abu Khalaf, Suha
    Riaz, Talha
    Mansour, Abdallah
    Doll, Donald
    BMJ CASE REPORTS, 2020, 13 (06)
  • [19] Molecular mediators of metastasis in head and neck squamous cell carcinoma
    Howell, GMS
    Grandis, JR
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2005, 27 (08): : 710 - 717
  • [20] Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck
    O-charoenrat, P
    Rhys-Evans, PH
    Eccles, SA
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2001, 127 (07) : 813 - 820